Abstract
Ferroptosis, a form of cell death caused by iron-dependent peroxidation of lipids, plays an important role in cancer. Recent studies have shown that long noncoding RNAs (lncRNAs) are involved in the regulation of ferroptosis in tumor cells and are also closely related to tumor immunity. Immune cell infiltration in the tumor microenvironment affects the prognosis and clinical outcome of immunotherapy in melanoma patients, and immune cell classification may be able to accurately predict the prognosis of melanoma patients. However, the prognostic value of ferroptosis-related lncRNAs (FRLs) in melanoma has not been thoroughly explored, and it is difficult to define the immune characteristics of melanoma. We used The Cancer Genome Atlas (TCGA), the Genotype-Tissue Expression (GTEx) database, and the FerrDb database to identify FRLs. FRLs with prognostic value were evaluated in an experimental cohort utilizing univariate, LASSO (least absolute shrinkage and selection operator) and multivariate Cox regression, followed by in vitro assays evaluating the expression levels and the biological functions of three candidate FRLs. Kaplan–Meier (K-M) and receiver operating characteristic (ROC) curve analyses were used to assess the validity of the risk model, and the drug sensitivity of FRLs was examined by drug sensitivity analysis. The differentially expressed genes between the high- and low-risk groups in the risk model were enriched in the immune pathway, and we further found immune gene signatures (IRGs) that could predict the prognosis of melanoma patients through a series of methods including single-sample Gene Set Enrichment Analysis (ssGSEA). Finally, two GEO cohorts were used to validate the predictive accuracy and reliability of these two signature models. Our findings suggest that FRLs and IRGs have the potential to predict the prognosis of patients with cutaneous melanoma.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon request.
References
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F (2021). Int J Cancer. https://doi.org/10.1002/ijc.33588
Laikova KV, Oberemok VV, Krasnodubets AM, Gal’chinsky NV, Useinov RZ, Novikov IA, Temirova ZZ, Gorlov MV, Shved NA, Kumeiko VV, Makalish TP, Bessalova EY, Fomochkina II, Esin AS, Volkov ME, Kubyshkin AV (2019). Molecules. https://doi.org/10.3390/molecules24081516
Siegel RL, Miller KD, Jemal A (2020) CA Cancer J Clin 70:7–30. https://doi.org/10.3322/caac.21590
Strub T, Ballotti R, Bertolotto C (2020) Theranostics 10:1777–1797. https://doi.org/10.7150/thno.36218
Sicco E, Mónaco A, Fernandez M, Moreno M, Calzada V, Cerecetto H (2021) Sci Rep 11:19942. https://doi.org/10.1038/s41598-021-98828-6
Schadendorf D, van Akkooi ACJ, Berking C, Griewank KG, Gutzmer R, Hauschild A, Stang A, Roesch A, Ugurel S (2018) Lancet 392:971–984. https://doi.org/10.1016/s0140-6736(18)31559-9
Pilla L, Alberti A, Di Mauro P, Gemelli M, Cogliati V, Cazzaniga ME, Bidoli P, Maccalli C (2020). Cancers (Basel). https://doi.org/10.3390/cancers12113456
Johann K, Bohn T, Shahneh F, Luther N, Birke A, Jaurich H, Helm M, Klein M, Raker VK, Bopp T, Barz M, Becker C (2021) Nat Commun 12:5981. https://doi.org/10.1038/s41467-021-26269-w
Zeng Y, Zeng Y, Yin H, Chen F, Wang Q, Yu X, Zhou Y (2021) Aging (Albany NY) 13:3459–3482. https://doi.org/10.18632/aging.202279
Galon J, Pagès F, Marincola FM, Thurin M, Trinchieri G, Fox BA, Gajewski TF, Ascierto PA (2012) J Transl Med 10:1. https://doi.org/10.1186/1479-5876-10-1
Ros-Martínez S, Navas-Carrillo D, Alonso-Romero JL, Orenes-Piñero E (2020) Crit Rev Clin Lab Sci 57:432–443. https://doi.org/10.1080/10408363.2020.1729692
Keung EZ, Gershenwald JE (2020) J Natl Cancer Inst 112:875–885. https://doi.org/10.1093/jnci/djaa012
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR (2012) Cell 149:1060–1072. https://doi.org/10.1016/j.cell.2012.03.042
Conrad M, Novikova M (2020) Signal Transduct Target Ther 5:261. https://doi.org/10.1038/s41392-020-00368-4
Talty R, Bosenberg M (2022) Pigment Cell Melanoma Res 35:18–25. https://doi.org/10.1111/pcmr.13009
Ashrafizadeh M, Mohammadinejad R, Tavakol S, Ahmadi Z, Roomiani S, Katebi M (2019) J Cell Physiol 234:19471–19479. https://doi.org/10.1002/jcp.28740
Tsoi J, Robert L, Paraiso K, Galvan C, Sheu KM, Lay J, Wong DJL, Atefi M, Shirazi R, Wang X, Braas D, Grasso CS, Palaskas N, Ribas A, Graeber TG (2018) Cancer Cell 33:890-904.e895. https://doi.org/10.1016/j.ccell.2018.03.017
Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, Galeas J, Dhruv HD, Berens ME, Schreiber SL, McCormick F, McManus MT (2017) Nature 551:247–250. https://doi.org/10.1038/nature24297
Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, Kaffenberger SD, Eaton JK, Shimada K, Aguirre AJ, Viswanathan SR, Chattopadhyay S, Tamayo P, Yang WS, Rees MG, Chen S, Boskovic ZV, Javaid S, Huang C, Wu X, Tseng YY, Roider EM, Gao D, Cleary JM, Wolpin BM, Mesirov JP, Haber DA, Engelman JA, Boehm JS, Kotz JD, Hon CS, Chen Y, Hahn WC, Levesque MP, Doench JG, Berens ME, Shamji AF, Clemons PA, Stockwell BR, Schreiber SL (2017) Nature 547:453–457. https://doi.org/10.1038/nature23007
Jiang Z, Lim SO, Yan M, Hsu JL, Yao J, Wei Y, Chang SS, Yamaguchi H, Lee HH, Ke B, Hsu JM, Chan LC, Hortobagyi GN, Yang L, Lin C, Yu D, Hung MC (2021). J Clin Invest. https://doi.org/10.1172/jci139434
Wang W, Green M, Choi JE, Gijón M, Kennedy PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, Xia H, Zhou J, Li G, Li J, Li W, Wei S, Vatan L, Zhang H, Szeliga W, Gu W, Liu R, Lawrence TS, Lamb C, Tanno Y, Cieslik M, Stone E, Georgiou G, Chan TA, Chinnaiyan A, Zou W (2019) Nature 569:270–274. https://doi.org/10.1038/s41586-019-1170-y
Liu Y, Zhang X, Zhang J, Tan J, Li J, Song Z (2020) Front Cell Dev Biol 8:596679. https://doi.org/10.3389/fcell.2020.596679
Batista PJ, Chang HY (2013) Cell 152:1298–1307. https://doi.org/10.1016/j.cell.2013.02.012
Wozniak M, Czyz M (2021). Cancers (Basel). https://doi.org/10.3390/cancers13194848
Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, Maher E, Kaye FJ, Sasaki H, Tepper JE, Fletcher JA, Tabernero J, Baselga J, Tsao MS, Demichelis F, Rubin MA, Janne PA, Daly MJ, Nucera C, Levine RL, Ebert BL, Gabriel S, Rustgi AK, Antonescu CR, Ladanyi M, Letai A, Garraway LA, Loda M, Beer DG, True LD, Okamoto A, Pomeroy SL, Singer S, Golub TR, Lander ES, Getz G, Sellers WR, Meyerson M (2010) Nature 463:899–905. https://doi.org/10.1038/nature08822
Beermann J, Piccoli MT, Viereck J, Thum T (2016) Physiol Rev 96:1297–1325. https://doi.org/10.1152/physrev.00041.2015
Wang Z, Chen X, Liu N, Shi Y, Liu Y, Ouyang L, Tam S, Xiao D, Liu S, Wen F, Tao Y (2021) Mol Ther 29:263–274. https://doi.org/10.1016/j.ymthe.2020.09.024
Xing XL, Zhang T, Yao ZY, Xing C, Wang C, Liu YW, Huang M (2021) Front Genet 12:690053. https://doi.org/10.3389/fgene.2021.690053
Petitprez F, Vano YA, Becht E, Giraldo NA, de Reyniès A, Sautès-Fridman C, Fridman WH (2018) Cancer Immunol Immunother 67:981–988. https://doi.org/10.1007/s00262-017-2058-z
Ladányi A (2015) Pigment Cell Melanoma Res 28:490–500. https://doi.org/10.1111/pcmr.12371
Selitsky SR, Mose LE, Smith CC, Chai S, Hoadley KA, Dittmer DP, Moschos SJ, Parker JS, Vincent BG (2019) Genome Med 11:36. https://doi.org/10.1186/s13073-019-0647-5
Iglesia MD, Parker JS, Hoadley KA, Serody JS, Perou CM, Vincent BG (2016). J Natl Cancer Inst. https://doi.org/10.1093/jnci/djw144
Zhou N, Bao J (2020). Database (Oxford). https://doi.org/10.1093/database/baaa021
Jian Z, Li K, Song P, Zhu G, Zhu L, Cui T, Liu B, Tang L, Wang X, Wang G, Gao T, Li C (2014) J Invest Dermatol 134:2221–2230. https://doi.org/10.1038/jid.2014.152
Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW, Levine DA, Carter SL, Getz G, Stemke-Hale K, Mills GB, Verhaak RG (2013) Nat Commun 4:2612. https://doi.org/10.1038/ncomms3612
Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA (2015) Nat Methods 12:453–457. https://doi.org/10.1038/nmeth.3337
Tan Y, Zhang S, Xiao Q, Wang J, Zhao K, Liu W, Huang K, Tian W, Niu H, Lei T, Shu K (2020) Genomics 112:4808–4816. https://doi.org/10.1016/j.ygeno.2020.08.035
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS (2017) Cancer Res 77:e108–e110. https://doi.org/10.1158/0008-5472.Can-17-0307
Cao JY, Dixon SJ (2016) Cell Mol Life Sci 73:2195–2209. https://doi.org/10.1007/s00018-016-2194-1
Yang WS, Stockwell BR (2016) Trends Cell Biol 26:165–176. https://doi.org/10.1016/j.tcb.2015.10.014
Ursini F, Maiorino M (2020) Free Radic Biol Med 152:175–185. https://doi.org/10.1016/j.freeradbiomed.2020.02.027
Skudalski L, Waldman R, Kerr PE, Grant-Kels JM (2022) J Am Acad Dermatol 86:515–524. https://doi.org/10.1016/j.jaad.2021.09.075
Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) CA Cancer J Clin 72:7–33. https://doi.org/10.3322/caac.21708
Lu B, Chen XB, Ying MD, He QJ, Cao J, Yang B (2017) Front Pharmacol 8:992. https://doi.org/10.3389/fphar.2017.00992
Yang Y, Luo M, Zhang K, Zhang J, Gao T, Connell DO, Yao F, Mu C, Cai B, Shang Y, Chen W (2020) Nat Commun 11:433. https://doi.org/10.1038/s41467-020-14324-x
Friedmann Angeli JP, Krysko DV, Conrad M (2019) Nat Rev Cancer 19:405–414. https://doi.org/10.1038/s41568-019-0149-1
Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, Li B (2019) J Hematol Oncol 12:34. https://doi.org/10.1186/s13045-019-0720-y
Gupta PB, Pastushenko I, Skibinski A, Blanpain C, Kuperwasser C (2019) Cell Stem Cell 24:65–78. https://doi.org/10.1016/j.stem.2018.11.011
Wang M, Mao C, Ouyang L, Liu Y, Lai W, Liu N, Shi Y, Chen L, Xiao D, Yu F, Wang X, Zhou H, Cao Y, Liu S, Yan Q, Tao Y, Zhang B (2020) Cell Death Differ 27:1447. https://doi.org/10.1038/s41418-019-0394-6
Xu Z, Peng B, Liang Q, Chen X, Cai Y, Zeng S, Gao K, Wang X, Yi Q, Gong Z, Yan Y (2021) Front Immunol 12:719175. https://doi.org/10.3389/fimmu.2021.719175
Zhang K, Ping L, Du T, Liang G, Huang Y, Li Z, Deng R, Tang J (2021) Front Mol Biosci 8:678877. https://doi.org/10.3389/fmolb.2021.678877
He Y, Wang X (2020) Ann Transl Med 8:1050. https://doi.org/10.21037/atm-20-922
Ma Y, Wang N, Yang S (2022) Aging (Albany NY) 14:3030–3048. https://doi.org/10.18632/aging.203982
Sun S, Zhang G, Zhang L (2021) Front Cell Dev Biol 9:790047. https://doi.org/10.3389/fcell.2021.790047
Guo K, Qian K, Shi Y, Sun T, Wang Z (2021) Cell Death Dis 12:1097. https://doi.org/10.1038/s41419-021-04386-0
Wang P, Chen Y, Zheng Y, Fu Y, Ding Z (2021) Dis Markers 2021:5340240. https://doi.org/10.1155/2021/5340240
Hou J, Wang Z, Li H, Zhang H, Luo L (2022) J Oncol 2022:9332844. https://doi.org/10.1155/2022/9332844
Zhang X, Zhang Q, Liu G (2022) Front Genet 13:992444. https://doi.org/10.3389/fgene.2022.992444
Wang Y, Lu G, Xue X, Xie M, Wang Z, Ma Z, Feng Y, Shao C, Duan H, Pan M, Ding P, Li X, Han J, Yan X (2022) Front Immunol 13:903758. https://doi.org/10.3389/fimmu.2022.903758
Long J, Liu L, Zhou X, Lu X, Qin L (2022) J Oncol 2022:7130634. https://doi.org/10.1155/2022/7130634
Zhong Q, Lu M, Yuan W, Cui Y, Ouyang H, Fan Y, Wang Z, Wu C, Qiao J, Hang J (2021) J Transl Med 19:58. https://doi.org/10.1186/s12967-021-02705-9
An J, Kim D, Oh B, Oh YJ, Song J, Park N, Kim HI, Kang HJ, Oh JH, Kim W, Lee E, Sung CO, Song GW, Kim DG, Yu E, Letouzé E, Zucman-Rossi J, Lee HC, Shim JH (2022) Hepatology 75:997–1011. https://doi.org/10.1002/hep.32135
Nazmeen A, Chen G, Maiti S (2020) Mol Biol Rep 47:4691–4698. https://doi.org/10.1007/s11033-020-05518-z
Liang W, Peng X, Li Q, Wang P, Lv P, Song Q, She S, Huang S, Chen K, Gong W, Yuan W, Thovarai V, Yoshimura T, O’Huigin C, Trinchieri G, Huang J, Lin S, Yao X, Bian X, Kong W, Xi J, Wang JM, Wang Y (2020) Nat Commun 11:5912. https://doi.org/10.1038/s41467-020-19691-z
Wan ZH, Ma YH, Jiang TY, Lin YK, Shi YY, Tan YX, Dong LW, Wang HY (2019) Hepatobiliary Pancreat Dis Int 18:525–531. https://doi.org/10.1016/j.hbpd.2019.09.005
Andrews LP, Marciscano AE, Drake CG, Vignali DA (2017) Immunol Rev 276:80–96. https://doi.org/10.1111/imr.12519
Wang W, Min K, Chen G, Zhang H, Deng J, Lv M, Cao Z, Zhou Y (2021) J Cancer 12:5967–5976. https://doi.org/10.7150/jca.58768
Chernyakov D, Groß A, Fischer A, Bornkessel N, Schultheiss C, Gerloff D, Edemir B (2021) J Exp Clin Cancer Res 40:226. https://doi.org/10.1186/s13046-021-01982-y
Wang C, Cicek MS, Charbonneau B, Kalli KR, Armasu SM, Larson MC, Konecny GE, Winterhoff B, Fan JB, Bibikova M, Chien J, Shridhar V, Block MS, Hartmann LC, Visscher DW, Cunningham JM, Knutson KL, Fridley BL, Goode EL (2014) Cancer Res 74:3084–3091. https://doi.org/10.1158/0008-5472.Can-13-3198
Meng Q, Hu X, Zhao X, Kong X, Meng YM, Chen Y, Su L, Jiang X, Qiu X, Huang C, Liu C, Wang M, Wong PP (2021) EBioMedicine 66:103301. https://doi.org/10.1016/j.ebiom.2021.103301
Su Q, Wang Y, Zhao J, Ma C, Wu T, Jin T, Xu J (2015) BMC Gastroenterol 15:107. https://doi.org/10.1186/s12876-015-0336-9
Guo S, Chen J, Yi X, Lu Z, Guo W (2022) Front Immunol 13:985051. https://doi.org/10.3389/fimmu.2022.985051
Ping S, Gong R, Lei K, Qing G, Zhang G, Chen J (2022) Discov Oncol 13:125. https://doi.org/10.1007/s12672-022-00581-3
Acknowledgements
This work was supported by the National Natural Science Foundation of China (82073019 and 82073018), Hunan Provincial Natural Science Foundation of China (under grant 2022JJ30189), Teaching Reform Research Project of Universities in HunanProvince (under grant HNJG-2021-1120), and Shenzhen Science and Technology Innovation Commission, China (Natural Science Foundation of Shenzhen, JCYJ20210324113001005 and JCYJ20210324114212035).
Author information
Authors and Affiliations
Contributions
Conception and design: Kaifen Xiong; Financial support: Min Qi, Zheng Wang and Jianglin Zhang; Administrative support: Li Peng, Min Qi, and Jianglin Zhang; Collection and assembly of data: Kaifen Xiong Alphonse Houssou Hounye, and Li Peng; Data analysis and interpretation: Kaifen Xiong, Zheng Wang, and Alphonse Houssou Hounye; Manuscript writing: All authors; Final approval of manuscript: All authors; accountable for all aspects of the work: All authors.
Corresponding authors
Ethics declarations
Conflict of interest
The concepts and information presented in this paper are based on research and are not commercially available. There are no conflicts to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xiong, K., Wang, Z., Hounye, A.H. et al. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients. Apoptosis 28, 840–859 (2023). https://doi.org/10.1007/s10495-023-01831-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-023-01831-7